JUNS
Jupiter Neurosciences, Inc.Company with tickers: JUNS
CIK
1679628
CUSIP
48208B203
Shares Outstanding
43,424,110
13F Activity (30d)
10 filings
10 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $18,652 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | $14,290 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Expenses | $1,977,290 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $411,049 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-1,963,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-2,061,958 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.06 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.06 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |